Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 27;53(6):1900084.
doi: 10.1183/13993003.00084-2019. Print 2019 Jun.

Impact of chest imaging quality on the diagnosis of the usual interstitial pneumonia pattern: a hub and spoke study

Giacomo Sgalla  1 , Anna Rita Larici  2   3 , Antonina Re  4 , Alessandra Farchione  3 , Giuseppe Cicchetti  2   3 , Lucio Calandriello  3 , Alessia Comes  5 , Nicoletta Golfi  5 , Bruno Iovene  5 , Francesco Varone  5 , Riccardo Manfredi  2   3 , Luca Richeldi  5   6
Affiliations
Free article

Impact of chest imaging quality on the diagnosis of the usual interstitial pneumonia pattern: a hub and spoke study

Giacomo Sgalla et al. Eur Respir J. .
Free article
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: G. Sgalla reports personal fees from Boehringer Ingelheim, outside the submitted work. Conflict of interest: A.R. Larici has nothing to disclose. Conflict of interest: A. Re has nothing to disclose. Conflict of interest: A. Farchione has nothing to disclose. Conflict of interest: G. Cicchetti has nothing to disclose. Conflict of interest: L. Calandriello has nothing to disclose. Conflict of interest: A. Comes has nothing to disclose. Conflict of interest: N. Golfi has nothing to disclose. Conflict of interest: B. Iovene has nothing to disclose. Conflict of interest: F. Varone has nothing to disclose. Conflict of interest: R. Manfredi has nothing to disclose. Conflict of interest: L. Richeldi reports personal fees for consultancy from Sanofi-Aventis, ImmuneWorks, Celgene, Nitto and Bristol Myers Squibb, personal fees for advisory board work from Roche, Fibrogen and Promedior, personal fees for lecturing from Shionogi, personal fees for steering committee work from Boehringer Ingelheim, personal fees for editorial activities from DynaMed, outside the submitted work.

Publication types